AEON Biopharma, Inc. SEC filings AEON

AEON Biopharma, Inc. has 361 filings in SEC EDGAR's recent list, going back to Dec 23, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 30, 2026 Dec 31, 2025
10-K/A Amended annual report Jun 11, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
10-K Annual report Mar 24, 2025 Dec 31, 2024
10-K/A Amended annual report Aug 12, 2024 Dec 31, 2023
10-K/A Amended annual report May 14, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 29, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 10, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 5, 2023 Dec 31, 2022
10-K Annual report Feb 22, 2023 Dec 31, 2022
10-K Annual report Mar 28, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AEON (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Aliso Viejo, CA
SEC filer status
, Emerging growth company
SEC CIK
1837607
Former names
Priveterra Acquisition Corp. (until Jul 24, 2023)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.